|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/138 | |
| A61K 31/439 | |||
| A61K 31/58 | |||
| A61P 11/06 | |||
| A61P 11/00 |
| (11) | Patento numeris | 3148521 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15726106.6 |
| Europos patento paraiškos padavimo data | 2015-05-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/061765 |
| Data | 2015-05-27 |
| (87) | Numeris | WO 2015/181262 |
| Data | 2015-12-03 |
| (30) | Numeris | Data | Šalis |
| 201462003764 P | 2014-05-28 | US | |
| 201462004304 P | 2014-05-29 | US | |
| 201462042506 P | 2014-08-27 | US |
| (72) |
BARNES, Neil Christopher, GB
PASCOE, Steven John, US
|
| (73) |
GlaxoSmithKline Intellectual Property Development Limited,
980 Great West Road, Brentford Middlesex TW8 9GS,
GB
|
| (54) | FLUTICASONE FUROATE IN THE TREATMENT OF COPD |
| FLUTICASONE FUROATE IN THE TREATMENT OF COPD |